Ropes & Gray advised Pfizer Inc. on its definitive agreement to acquire Hospira, the Lake Forest, Ill.-based leading provider of injectable drugs and infusion technologies and a worldwide leader in biosimilars, for a total value of approximately $17 billion. The deal was announced Feb. 5 and is expected to close in the second half of 2015.
Securities & public companies partners Marko Zatylny and Paul Kinsella led the Ropes & Gray team advising Pfizer on the transaction.
Source: www.ropesgray.com
